SCHEMBL9200751

SCHEMBL9200751

CCOC(=O)c1cc(NC(=O)C2=C(CC)OCCS2)ccc1Cl

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.50
ALDH1A1 P00352 1/20 0.48
MEN1 O00255 7/20 0.44
NPC1 O15118 3/20 0.44
USP2 O75604 1/20 0.43
ACR P10323 1/20 0.43
MAPK1 P28482 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CYP4F2 P78329 1/20 0.41
CYP4A11 Q02928 1/20 0.41
LMNA P02545 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
POLB P06746 2/20 0.41
RAB9A P51151 3/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9199116 0.92 KMT2A (0.48) KMT2AALDH1A1MEN1NPC1USP2
SCHEMBL9198181 0.91 KMT2A (0.42) KMT2AALDH1A1MEN1NPC1USP2
SCHEMBL9199898 0.90 MAPK1 (0.55) KMT2AALDH1A1MEN1NPC1MAPK1
SCHEMBL9196732 0.89 KMT2A (0.43) KMT2AMEN1NPC1USP2MAPK1
SCHEMBL27322987 0.88 MAPK1 (0.46) KMT2AALDH1A1MEN1NPC1MAPK1
SCHEMBL9196974 0.86 USP2 (0.48) KMT2AALDH1A1MEN1NPC1USP2
SCHEMBL9196878 0.83 MAPK1 (0.52) KMT2AMEN1NPC1MAPK1HSD17B10
SCHEMBL9199871 0.83 MAPK1 (0.52) KMT2AMEN1NPC1MAPK1HSD17B10
SCHEMBL9196919 0.82 MAPK1 (0.58) KMT2AMEN1NPC1USP2MAPK1
SCHEMBL9200225 0.82 MAPK1 (0.50) KMT2AMEN1NPC1MAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0497816-B1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD (CA) 1995-05-17 EP claimed
EP-0497816-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN. UNIROYAL CHEMICAL LTD (CA) 1992-08-12 EP claimed
WO-1991005761-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD./UNIROYAL CHEMICAL LTEE (CA) 1991-05-02 WO claimed
CN-1051036-A The treatment of HIV (human immunodeficiency virus) infections and in treatment used compound UNIROYAL CHEM CO INC (US) 1991-05-01 CN claimed
EP-0497816-B1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD (CA) 1995-05-17 EP disclosed
US-5268389-A Containing a benzene ring UNIROYAL CHEMICAL COMPANY, INC. (US) 1993-12-07 US disclosed
EP-0497816-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN. UNIROYAL CHEMICAL LTD (CA) 1992-08-12 EP disclosed
WO-1991005761-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD./UNIROYAL CHEMICAL LTEE (CA) 1991-05-02 WO disclosed
CN-1051036-A The treatment of HIV (human immunodeficiency virus) infections and in treatment used compound UNIROYAL CHEM CO INC (US) 1991-05-01 CN disclosed